GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.520
+0.020 (0.80%)
May 19, 2026, 4:00 PM EDT - Market closed
GoodRx Holdings Revenue
GoodRx Holdings had revenue of $194.01M in the quarter ending March 31, 2026, a decrease of -4.42%. This brings the company's revenue in the last twelve months to $787.89M, down -1.19% year-over-year. In the year 2025, GoodRx Holdings had annual revenue of $796.85M with 0.57% growth.
Revenue (ttm)
$787.89M
Revenue Growth
-1.19%
P/S Ratio
1.08
Revenue / Employee
$1,130,400
Employees
697
Market Cap
853.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 796.85M | 4.53M | 0.57% |
| Dec 31, 2024 | 792.32M | 42.06M | 5.61% |
| Dec 31, 2023 | 750.27M | -16.29M | -2.12% |
| Dec 31, 2022 | 766.55M | 21.13M | 2.83% |
| Dec 31, 2021 | 745.42M | 194.72M | 35.36% |
| Dec 31, 2020 | 550.70M | 162.48M | 41.85% |
| Dec 31, 2019 | 388.22M | 138.70M | 55.59% |
| Dec 31, 2018 | 249.52M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.51B |
| Evolent Health | 1.89B |
| Phreesia | 480.59M |
| Certara | 419.75M |
| TruBridge | 345.90M |
| HealthStream | 311.78M |
| Omada Health | 283.30M |
| Schrödinger | 254.91M |
GDRX News
- 5 days ago - GoodRx price target raised to $4 from $3.50 at Citi - TheFly
- 8 days ago - GoodRx price target raised to $4 from $3 at TD Cowen - TheFly
- 11 days ago - GoodRx price target raised to $3.50 from $2.50 at Goldman Sachs - TheFly
- 12 days ago - Big Pharma Runs Its Checkout Counter Through GoodRx - PYMNTS
- 12 days ago - GoodRx Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - GoodRx Holdings Quarterly report: Q1 2026 - Filings
- 12 days ago - GoodRx Holdings Earnings release: Q1 2026 - Filings
- 13 days ago - GoodRx Reports First Quarter 2026 Results - Business Wire